Additionally, CLDN2 displays elevated expression in human lung adenocarcinoma cells and contributes to enhanced cell proliferation, while its knockdown has been shown to increase paracellular permeability and intracellular accumulation of doxorubicin in tumor spheroids. The gene discussed is CLDN2; the disease is lung adenocarcinoma.